ºÚÁÏÍø

The Journal of Pulmonology and Respiratory Diseases is a high-quality open access Journal dedicated to publish the latest advancements to address respiratory diseases and in the field of Pulmonology. The Journal of Pulmonology and Respiratory Diseases thus focuses on the progressive lung diseases like chronic bronchitis and emphysema. The Journal also encompasses the complications of Respiratory Diseases such as: Acute Exacerbation, Pneumonia, Pulmonary Hypertension, Pulmonary Aspergillosis, Lung collapse, Lung cancer, Respiratory Failure, and Heart Failure.

Currently, Respiratory Disease is rampant across the World, so special focus is placed on Respiratory Disease diagnosis, management, and treatment such as: Spirometry, Mechanical Ventilation, Long Term Oxygen Therapy, Long-acting beta agonists (LABAs), Corticosteroids,and Tumor necrosis factor alpha (TNFα) inhibitors. The scope of the Journal also encompasses other related lung diseases such as interstitial lung disease (ILD), and associated conditions such as: idiopathic pulmonary fibrosis and auto-immune related pulmonary disorders. Apart from catering to the needs of the scholars who wish to stay at leading-edge of the field, the journal also targets people from non-scientific backgrounds as end users.

The editorial board comprised of globally recognized scientists oversees the allocation of the manuscripts for peer-review; eminent scientists in the field are involved in the manuscript review process. The published content is therefore exceptional in terms of quality and originality. In addition to Research Articles, the Journal also publishes high quality Commentaries, Reviews, Perspectives, and Case Reports of considerable impact.

The Journal aims to provide all the authors with a streamlined editorial process. The Journal of Pulmonology and Respiratory Diseases takes immense pride in facilitating rapid publishing of articles by ensuring barrier-free distribution of its content through its online open access format.The Journal of Pulmonology and Respiratory Diseases provides an encouraging and stimulating platform to authors for making their valuable contributions towards research in respiratory disorders.

 

Pneumonia Pathogenesis

Pneumonia pathogenesis involves the invasion of lung tissue by pathogens such as bacteria, viruses, or fungi, leading to an in the alveoli. The most common bacterial cause is Streptococcus pneumoniae. The pathogens trigger an immune response, resulting in the accumulation of fluid, , and inflammatory mediators in the alveoli, impairing gas exchange. This leads to symptoms like fever, cough, and difficulty breathing. Host factors such as weakened immunity, underlying conditions, or environmental exposure can increase susceptibility. Severe cases may result in respiratory failure or , necessitating prompt medical intervention.

Pediatric Respiratory Disorders

Pediatric respiratory disorders encompass a range of conditions affecting the respiratory system in children, including both acute and chronic illnesses. Common disorders include , characterized by chronic inflammation and airway obstruction; infections, which can lead to severe respiratory symptoms; and cystic fibrosis, a genetic disorder causing thick mucus buildup in the lungs. Other conditions include , and (bronchopulmonary dysplasia BPD) in premature infants. These disorders can impact necessitating specialized diagnosis and management to ensure optimal respiratory health and quality of life for affected children.

Asthma Management

Effective asthma management involves a comprehensive approach to control symptoms and prevent exacerbations. Key strategies include using inhaled corticosteroids and bronchodilators as prescribed, monitoring peak flow rates to track , and avoiding triggers such as allergens, smoke, and pollutants. Patients should follow a personalized action plan developed with their healthcare provider, which includes recognizing early signs of an asthma attack and knowing when to seek medical help. Regular follow-ups with a healthcare provider ensure that the treatment plan remains effective and adjusted as needed. Education on proper inhaler technique and lifestyle modifications are also crucial for optimal control.

Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of cases. It encompasses several subtypes, including , squamous cell carcinoma, and large cell carcinoma. NSCLC typically presents with symptoms such as persistent cough, chest pain, and weight loss. Diagnosis is often made through imaging and biopsy. Treatment options vary based on the stage and include surgery, chemotherapy, radiation therapy, and targeted therapies. Recent advances focus on personalized medicine and , aiming to improve outcomes and reduce side effects. Ongoing research is essential for developing novel treatments and improving patient prognosis.

Chronic Airflow Obstruction

Chronic airflow obstruction or chronic obstructive pulmonary disease (COPD) is one of the obstructive lung diseases of poor airflow. Smoking is the main cause of airflow obstruction. The main symptoms of this disease include shortness of breath and cough. Treatment to that particular disease will slow worsening but there is no cure. In most cases we can prevent this disease by reducing exposure to risk factors such as decreasing the rate of smoking and improving the quality of indoor and outdoor air. There are some treatments to reduce the worsening of this disease include quitting smoking, vaccinations, respiratory rehabilitations and steroids.

Related journals: Journal of Pulmonary & Respiratory Medicine Journal of Clinical Respiratory Diseases and Care Air & Water Borne Diseases American Journal of Physiology - Lung Cellular and Molecular Physiology American Journal of Respiratory Cell and Molecular Biology Journal of Heart and Lung Transplantation International Journal of Tuberculosis and Lung Disease Heart and Lung: Journal of Acute and Critical Care Lung Experimental Lung Research Heart Lung and Circulation

Chronic Lung Disease

Chronic lung disease is also known as bronchopulmonary dysplasia. It is a health problem occurs when a baby has damaged tissue in the lungs. Due to that the tissue will be inflamed and may be break down. In that case it will be difficult to that baby to breath, there they need oxygen therapy. It is most common disease in premature babies. The most common symptoms in this disease include fast breath, pale, grey, or blotchy skin, use the neck, chest and belly muscles to breathe, tiring during and after feeding.

Related journals: Journal of Pulmonary & Respiratory Medicine Journal of Clinical Respiratory Diseases and Care Clinics in Mother and Child Health Journal of Pregnancy and Child Health Sarcoidosis Vasculitis and Diffuse Lung Diseases Infant Mental Health Journal Infant and Child Development Newborn and Infant Nursing Review

Chronic Obstructive Airway Disease

Chronic obstructive airway disease is a health condition that makes the people hard to breathe. Tobacco consumption is the major cause of this disease. Exposure to other lung irritants, air pollution, chemical fumes or dust may also cause chronic obstructive airway disease. This disease will include emphysema means damage to the air sacs in the lungs and chronic bronchitis (long-term inflammation of the airways). The main symptoms include increasing breathlessness, persistent chesty cough, wheezing, chest infections.

Related journals: Journal of Pulmonary & Respiratory Medicine Journal of Clinical Respiratory Diseases and Care Journal of Lung Diseases & Treatment Journal of Clinical Respiratory Diseases and Care Chronic Respiratory Disease Lung India Expert Review of Respiratory Medicine American Journal of Respiratory Cell and Molecular Biology

Bronchopulmonary Disease

It is a most common chronic lung disease of infants with low birth weight. And it was most common to those infants who receive prolonged mechanical ventilation to treat respiratory distress syndrome. The symptoms of this disease will depend on the severity of the problem. The most common symptoms are rapid breathing, wheezing, poor growth, repeated lung infections. The main risk factors include degree of prematurity, prolonged mechanical ventilation, high concentrations of oxygen, male gender, maternal conditions and etc.

Related journals: Journal of Pulmonary & Respiratory Medicine Journal of Clinical Respiratory Diseases and Care Clinics in Mother and Child Health Journal of Pregnancy and Child Health Sarcoidosis Vasculitis and Diffuse Lung Diseases Child Development Infant and Child Development Newborn and Infant Nursing Review Infancy

Chronic Respiratory Disease

Chronic respiratory disease is a disease of airways and structures of lung. This will include asthma, chronic obstructive airway disease, lung disease and hypertension. The common risk factors of this disease include people aged more than 60, Women, asthma patients. We can prevent this disease by reducing the exposure to tobacco smoking, air pollution. Chronic respiratory diseases are not curable, however, various forms of treatment that help dilate major air passages and improve shortness of breath can help control symptoms and increase the quality of life for people with the disease.

Related journals: Journal of Pulmonary & Respiratory Medicine Journal of Clinical Respiratory Diseases and Care Journal of Smoking Cessation Water, Air, and Soil Pollution: Focus Advances in Air Pollution Air & Water Borne Diseases Tobacco Control Nicotine & Tobacco Researchs

Pulmonary Emphysema

Pulmonary Emphysema in the broadest sense of the word is pneumatosis, that is, any abnormal accumulation of air or other gas within animal tissues. In the most common sense of the word it is a type of chronic obstructive pulmonary disease.

Related Journals of Pulmonary Emphysema
American Journal of Respiratory and Critical Care Medicine, The Lancet Respiratory Medicine, Journal of Heart and Lung Transplantation, European Respiratory Journal, European Respiratory Review, Influenza and other Respiratory Viruses
 

Obstructive Lung Disease

Obstructive Lung Disease is a category of respiratory disease characterized by airway obstruction. Many obstructive diseases of the lung result from narrowing of the smaller bronchi and larger bronchioles, often because of excessive contraction of the smooth muscle itself. It is generally characterized by inflamed and easily collapsible airways, obstruction to airflow, problems exhaling and frequent medical clinic visits and hospitalizations. Types of obstructive lung disease include; asthma, bronchiectasis, bronchitis and chronic obstructive pulmonary disease (COPD).

Related Journals of Obstructive Lung Disease
Journal of Aerosol Medicine and Pulmonary Drug Delivery, COPD: Journal of Chronic Obstructive Pulmonary Disease, Journal of Breath Research, Clinics in Chest Medicine, Respiration: international review of thoracic diseases, Seminars in Respiratory and Critical Care Medicine
 

Obstructive Respiratory Tract Disease

Obstructive Respiratory Tract Disease is a medical term that encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing. Respiratory diseases range from mild and self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, acute asthma and lung cancer.

Related Journals of Obstructive Respiratory Tract Disease
Journal of Thoracic Imaging, Experimental Lung Research, Interactive Cardiovascular and Thoracic Surgery, Respiratory Investigation, Pulmonary Medicine, Clinical Respiratory Journal
 

Chronic Pulmonary Disease

Chronic Pulmonary Disease also known as chronic obstructive lung disease (COLD), and chronic obstructive airway disease (COAD), is a collection of diseases which make breathing gradually more difficult. Symptoms of COPD include difficulty breathing and cough, in particular coughing up lots of phlegm. It is usually caused by smoking cigarettes, and around half of people who smoke for their whole lives will develop COPD. Air pollution can be another cause, particularly in countries where indoor fires are used without ventilation.

Related Journals of Chronic Pulmonary Disease
Archivos de Bronconeumologia, General Thoracic and Cardiovascular Surgery, Heart and Lung: Journal of Acute and Critical Care, Canadian Respiratory Journal, Thoracic and Cardiovascular Surgeon, Tuberculosis and Respiratory Diseases, Annals of Thoracic Medicine, Open Respiratory Medicine Journal
 

Pulmonary Medicine

Pulmonary Medicine is a medical speciality that deals with diseases involving the respiratory tract. It deals with chest medicine and respiratory medicine in some countries and areas. Pulmonology is considered a branch of internal medicine, and is related to intensive care medicine. Pulmonology often involves managing patients who need life support and mechanical ventilation. Pulmonologists are specially trained in diseases and conditions of the chest, particularly pneumonia, asthma, tuberculosis, emphysema, and complicated chest infections.

Related Journals of Pulmonary Medicine
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Clinical Pulmonary Medicine, Current Respiratory Medicine Reviews, Clinical Respiratory Journal, Pulmonary Medicine
 

Infliximab

Infliximab is used for treating the inflammation of Crohn's disease, rheumatoid arthritis, psoriasis, ankylosing spondylitis, and psoriatic arthritis. Infliximab is an antibody administered intravenously that is used for treating several chronic inflammatory diseases. Infliximab works by blocking the effects of tumor necrosis factor alpha (TNF alpha), a substance made by cells of the body which has an important role in promoting inflammation. Infliximab does not cure Crohn's disease, psoriatic arthritis, or rheumatoid arthritis. Infliximab can retard the destruction of joints by rheumatoid arthritis.

Related Journals of Infliximab
Journal of Tumor Research ºÚÁÏÍø Journal, Journal of Immunobiology, Journal of Immunological Techniques & Infectious Diseases, Journal of Immunooncology, Journal of Molecular Immunology, Journal of Mucosal Immunology Research
 

Respiratory Rehabilitation

Respiratory rehabilitation is a program of activity, instruction, and support to enable you to figure out how to inhale—and work—at the most abnormal amount conceivable. Fundamentally, it's a formal program that will assemble your wellness and enable you to inhale and additionally you can. Pneumonic recovery will assist you with Exercise, Breathing systems, Sustenance, Unwinding, Enthusiastic and gather bolster, Adapting more about your prescriptions, Systems for living better with COPD.

Related Journals: American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, American Journal of Respiratory Cell and Molecular Biology, Respiratory Medicine, Respiratory Physiology and Neurobiology, Respiratory Research

Bronchiectasis

Bronchiectasis is a disease or restorative condition, for example, pneumonia or cystic fibrosis. Bodily fluid develops and breeds microscopic organisms, causing incessant contaminations. Side effects incorporate an everyday hack that happens over months or years and day by day generation of a lot of mucus. Treatment may incorporate physiotherapy and prescription, for example, anti-toxins and medications to help slacken bodily fluid.Bronchiectasis is generally a procured bronchopulmonary scatter with unusual thickening of the bronchial divider and enlargement of focal and medium estimated bronchi, because of an endless loop of transmural disease and irritation with middle person discharge.

Related Journals: Journal of Physiotherapy, European Respiratory Journals, American Journal of Respiratory and Critical Care Medicine, The new englamd journal of medicine, American Journal of Roentgenology

Pneumothorax

Pneumothorax is characterized as the nearness of air or gas in the pleural depression (ie, the potential space between the instinctive and parietal pleura of the lung), which can impede oxygenation as well as ventilation. The clinical outcomes are reliant on the level of crumple of the lung on the influenced side. On the off chance that the pneumothorax is huge, it can cause a move of the mediastinum and bargain hemodynamic strength. A pneumothorax can be caused by a limit or entering trunk damage, certain medicinal strategies, or harm from basic lung ailment. Or, on the other hand it might happen for no conspicuous reason. Manifestations more often than exclude sudden trunk torment and shortness of breath. On a few events, a crumpled lung can be an existence debilitating occasion.

Related Journals: Journal of the American Academy of Physician Assistants, American journal of roentgenology, Journal of Emergency Medicine, Serbian Journal of Experimental and Clinical Research, European respiratory journal.

Pulmonary Edema

Pulmonary Edema may be a condition caused by excess fluid within the lungs. This fluid collects within the various air sacs within the lungs, creating it tough to breathe. This is usually caused by symptom heart disease. once the center isn't ready to pump with efficiency, blood will keep a copy into the veins that take blood through the lungs. As the pressure in these blood vessels will increase, fluid is pushed into the air areas (alveoli) within the lungs. This fluid reduces traditional element movement through the lungs. These 2 factors mix to cause shortness of breath.

Related Journals: Current Opinion in Pulmonary Medicine, Pulmonary Pharmacology and Therapeutics, Journal of Cardiopulmonary Rehabilitation and Prevention, Journal of Aerosol Medicine and Pulmonary Drug Delivery, COPD: Journal of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

is a progressive respiratory disorder characterized by persistent airflow limitation and inflammation. Commonly caused by long-term exposure to irritants like cigarette smoke and pollutants, COPD includes conditions such as emphysema and chronic bronchitis. Symptoms typically involve chronic cough, sputum production, and breathlessness, which worsen over time. The disease significantly impacts quality of life and increases the risk of and cardiovascular issues. Management focuses on smoking cessation, medications (e.g., bronchodilators, corticosteroids), pulmonary rehabilitation, and to alleviate symptoms and improve function.